Facultad de Medicina (FM)
Centro académico
Sungkyunkwan University
Seúl, Corea del SurPublicacións en colaboración con investigadores/as de Sungkyunkwan University (6)
2023
-
Antibodies against endogenous retroviruses promote lung cancer immunotherapy
Nature, Vol. 616, Núm. 7957, pp. 563-573
2021
-
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Journal of Clinical Oncology, Vol. 39, Núm. 27, pp. 2991-3001
2020
-
An international multicenter study of protocols for liver transplantation during a pandemic: A case for quadripartite equipoise
Journal of Hepatology, Vol. 73, Núm. 4, pp. 873-881
-
Efficacy and Safety of Nivolumab plus Ipilimumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib: The CheckMate 040 Randomized Clinical Trial
JAMA Oncology
2016
-
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial
The Lancet, Vol. 387, Núm. 10027, pp. 1540-1550
2013
-
Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis
PLoS ONE, Vol. 8, Núm. 11